drug

revakinagene taroretcel

Marketedupdated 4mo ago

by Neurotech Pharmaceuticals Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying revakinagene taroretcel

phase4Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participantsrecruitingn=234

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 12m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

revakinagene taroretcel

Marketedupdated 4mo ago

by Neurotech Pharmaceuticals Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying revakinagene taroretcel

phase4Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participantsrecruitingn=234

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 12m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

revakinagene taroretcel

all catalysts(0)

Trials studying revakinagene taroretcel

News(0)

Report a data issue

comments(0)

revakinagene taroretcel

all catalysts(0)

Trials studying revakinagene taroretcel

News(0)

Report a data issue

comments(0)